Neurocrine Biosciences Inc (NBIX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

102.50M
Year ended 2025-12-31
+1.2%
3-year compound annual growth
+0.9%
5-year compound annual growth
+2.0%
10-year compound annual growth
103.70M2009-12-31: 39.14M2010-12-31: 52.82M2011-12-31: 56.35M2012-12-31: 66.95M2013-12-31: 66.99M2014-12-31: 74.58M2015-12-31: 84.50M2016-12-31: 86.71M2017-12-31: 88.09M2018-12-31: 95.40M2019-12-31: 95.70M2020-12-31: 97.80M2021-12-31: 97.90M2022-12-31: 98.90M2023-12-31: 101.00M2024-12-31: 103.70M2025-12-31: 102.50M102.50M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31102.50M-1.2%2026-02-11, From 2025-01-01
2024-12-31103.70M+2.7%2026-02-11, From 2024-01-01
2023-12-31101.00M+2.1%2026-02-11, From 2023-01-01
2022-12-3198.90M+1.0%2025-02-10, From 2022-01-01
2021-12-3197.90M+0.1%2024-02-09, From 2021-01-01
2020-12-3197.80M+2.2%2023-02-09, From 2020-01-01
2019-12-3195.70M+0.3%2022-02-11, From 2019-01-01
2018-12-3195.40M+8.3%2021-02-05, From 2018-01-01
2017-12-3188.09M+1.6%2020-02-07, From 2017-01-01
2016-12-3186.71M+2.6%2019-02-08, From 2016-01-01
2015-12-3184.50M+13.3%2018-02-13, From 2015-01-01
2014-12-3174.58M+11.3%2017-02-14, From 2014-01-01
2013-12-3166.99M+0.1%2016-02-11, From 2013-01-01
2012-12-3166.95M+18.8%2015-02-09, From 2012-01-01
2011-12-3156.35M+6.7%2014-02-11, From 2011-01-01
2010-12-3152.82M+35.0%2013-02-08, From 2010-01-01
2009-12-3139.14Mn/a2012-02-09, From 2009-01-01